676 Results

People

  1. Robson
    Robson
  2. Offit
    Offit
  3. Stadler
    Stadler
  4. Joseph
    Joseph
  5. Mandelker
    Mandelker
  6. Berger
    Berger
  7. Solit
    Solit
  8. Hudis
    Hudis
  9. Kauff
    Kauff
  10. Kemel
    Kemel

Groups

  1. Breast Medicine Service (676)
  2. Department of Medicine (676)
  3. Population Sciences Research Program (676)
  4. Solid Tumor Oncology Division (676)
  5. Survivorship Research (676)
  6. GSK Faculty (376)
  7. Clinical Genetics Service (297)
  8. Surgery (188)
  9. Department of Pathology and Laboratory Medicine (187)
  10. Epidemiology and Biostatistics (185)
  1. "Mark Robson"
Formats
  1. Journal Article (382)
  2. Meeting Abstract (259)
  3. Review (10)
  4. Book Section (7)
  5. Editorial (6)
  6. Guidelines (6)
  7. Miscellaneous (4)
  8. Correspondence (1)
  9. Research Letter (1)
Groups
  1. Breast Medicine Service (676)
  2. Department of Medicine (676)
  3. Population Sciences Research Program (676)
  4. Solid Tumor Oncology Division (676)
  5. Survivorship Research (676)
  6. GSK Faculty (376)

More Groups

People
  1. Mark Robson (676)
  2. Kenneth Offit (280)
  3. Zsofia Stadler (116)
  4. Larry Norton (89)
  5. Vijai Joseph (79)
  6. Diana Mandelker (74)

More People

Years
  1. 2025 (2)
  2. 2024 (32)
  3. 2023 (41)
  4. 2022 (34)
  5. 2021 (46)
  6. 2020 (65)

More Years

Publications
  1. Journal of Clinical Oncology (163)
  2. Cancer Research (50)
  3. Breast Cancer Research and Treatment (33)
  4. JNCI: Journal of the National Cancer Institute (20)
  5. Annals of Oncology (18)
  6. Clinical Cancer Research (17)

More Publications

Publishers
  1. American Society of Clinical Oncology (185)
  2. American Association for Cancer Research (82)
  3. Springer (66)
  4. Nature Publishing Group (60)
  5. Elsevier Inc. (50)
  6. Oxford University Press (42)

More Publishers

Results (676)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • In silico evaluation of the 12-gene molecular score (EndoPredict) and the recurrence score (Oncotype DX) as predictors of response to neo-adjuvant chemotherapy in estrogen receptor positive (ER+), HER2 negative (HER2-) breast cancer
    Meeting Abstract

    Soliman, H. H.; Robson, M. E.; Wagner, S.; Flake, D. D.; Schwartzberg, L. S.; Sharma, P.; Magliocco, A. M.; Kronenwett, R.; Lancaster, J. M.; Lanchbury, J. S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Predicting expected absolute chemotherapy treatment benefit in women with early-stage breast cancer using a 12-gene expression assay
    Meeting Abstract

    Gradishar, W. J.; Robson, M. E.; Flake, D. D.; Schwartzberg, L. S.; Sharma, P.; Soliman, H. H.; Magliocco, A. M.; Brown, K.; Wehnelt, S.; Gutin, A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study
    Journal Article

    Brooks, J. D.; Comen, E. A.; Reiner, A. S.; Orlow, I.; Leong, S. F.; Liang, X.; Mellemkjær, L.; Knight, J. A.; Lynch, C. F.; John, E. M.; more...
    Breast Cancer Research (2018)

    Fulltext@MSK | Save
  • Pathogenic mutations in ATM enhance radio-sensitivity and local control in patients with primary and metastatic breast cancer
    Meeting Abstract

    Casey, D. L.; Pitter, K. L.; Setton, J.; Braunstein, L. Z.; Robson, M. E.; Reis-Filho, J.; Weigelt, B.; Lu, C.; Powell, S. N.; Chan, T. A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2018)

    Fulltext@MSK | Save
  • Histopathologic characteristics of background parenchymal enhancement (BPE) on breast MRI
    Journal Article

    Sung, J. S.; Corben, A. D.; Brooks, J. D.; Edelweiss, M.; Keating, D. M.; Lin, C.; Morris, E. A.; Patel, P.; Robson, M.; Woods, M.; more...
    Breast Cancer Research and Treatment (2018)

    Fulltext@MSK | Save
  • The landscape of somatic genetic alterations in breast cancers from ATM germline mutation carriers
    Journal Article

    Weigelt, B.; Bi, R.; Kumar, R.; Blecua, P.; Mandelker, D. L.; Geyer, F. C.; Pareja, F.; James, P. A.; for the kConFab Investigators; Couch, F. J.; more...
    JNCI: Journal of the National Cancer Institute (2018)

    Fulltext@MSK | Save
  • Quality of life with talazoparib after platinum or multiple cytotoxic non-platinum regimens in patients with advanced breast cancer and germline BRCA1/2 mutations: Patient-reported outcomes from the ABRAZO phase 2 trial
    Journal Article

    Hurvitz, S. A.; Quek, R. G. W.; Turner, N. C.; Telli, M. L.; Rugo, H. S.; Mailliez, A.; Ettl, J.; Grischke, E.; Mina, L. A.; Balmaña, J.; more...
    European Journal of Cancer (2018)

    Fulltext@MSK | Save
  • Prevalence of germline mutations in cancer susceptibility genes in patients with advanced renal cell carcinoma
    Journal Article

    Carlo, M. I.; Mukherjee, S.; Mandelker, D.; Vijai, J.; Kemel, Y.; Zhang, L.; Knezevic, A.; Patil, S.; Ceyhan-Birsoy, O.; Huang, K. C.; more...
    JAMA Oncology (2018)

    Fulltext@MSK | Save
  • Moderate-penetrance predisposition to breast cancer
    Journal Article

    Robson, M.
    Current Breast Cancer Reports (2018)

    Fulltext@MSK | Save
  • Resurrection of PARP inhibitors in breast cancer
    Journal Article

    Lyons, T. G.; Robson, M. E.
    Journal of the National Comprehensive Cancer Network (2018)

    Fulltext@MSK | Save